Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMYXR.L Regulatory News (MYXR)

  • There is currently no data for MYXR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of CFO and Board Director

13 Sep 2012 07:00

RNS Number : 1492M
MyCelx Technologies Corporation
12 September 2012
 



This press release does not constitute or form a part of, and should not be construed as, any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for, any securities in MyCelx Technologies Corporation ("MyCelx" or the "Company").

 

THE COMPANY'S COMMON SHARES HAVE NOT BEEN REGISTERED UNDER THE US SECURITIES ACT OF 1933, AS AMENDED (THE "US SECURITIES ACT") OR ANY STATE SECURITIES LAWS (THE "STATE ACTS") AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS UNLESS THE SECURITIES ARE REGISTERED UNDER THE US SECURITIES ACT AND ANY APPLICABLE STATE ACTS, OR AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE US SECURITIES ACT AND ANY APPLICABLE STATE ACTS IS AVAILABLE.

 

13 September, 2012

 

 

MYCELX TECHNOLOGIES CORPORATION

("MyCelx Technologies, Inc, or the "Company")

 

Appointment of Chief Financial Officer and Board Director; Grant of Options

 

MyCelx Technologies, Inc (AIM - common shares: MYXR / DI: MYX), the clean water technology company providing patented solutions for commercial industrial markets worldwide, is pleased to announce the appointment of Mark David Clark, 48, as Chief Financial Officer ("CFO"), Treasurer and a member of the MyCelx Board with immediate effect. This follows his appointment as Interim CFO, as announced on 9 May 2012.

 

Mr Clark joined MyCelx in October 2011 following a 14 year career at Invesco, Ltd. He is a Certified Public Accountant and holds a BBA in Accounting (Magna Cum Laude) from the University of Louisiana at Monroe.

 

There is no other information that is required to be disclosed with regards to the above mentioned appointment pursuant to Schedule 2 paragraph (g) of the AIM Rules.

 

Mark Clark was granted an option on 11 September 2012 under the MyCelx Omnibus Performance Incentive Plan over the Company's common shares of US$0.025 each. The grant was as follows:

 

Name of Director

Number of share options granted

Exercise price

Total number of share options held following this notification

Total number of share options as % of current issued share capital

Mark Clark

90,000

US$4.02*

100,000

0.8%

 

*Based on the mid-market closing price of the Company's common shares at 11 September 2012, and the closing US/£ exchange rate at that date.

 

 

The share options granted on 11 September 2012 will vest as follows: 30,000 vest immediately; 30,000 vest on 1 September 2013, and the remaining 30,000 vest on 1 September 2014. Following vesting, the options are exercisable up to 10 years from the date of vesting, subject to the restrictions on dealing under the Company's share dealing code. Mark Clark does not hold any other shares in the Company.

 

 

 

 

 

Appointment of Business Development Director

 

The Company is also pleased to announce the appointment with immediate effect of Nick Stamp as Business Development Director for Europe and Asia. Mr Stamp qualified as a Chartered Accountant in 2004 with Ernst & Young, and has 11 years' experience in the natural resources sector, most recently in corporate finance with Numis Securities Limited and Collins Stewart Hawkpoint plc.

 

 

Commenting on today's announcement, Connie Mixon, CEO, said:

"We are delighted to formalise Mark's appointment as CFO and Treasurer and to welcome him to the Board. We are also pleased to welcome Nick as Business Development Director to assist the Company's future growth in both Europe and Asia."

 

 

 

Enquiries

 

MyCelx Technologies Corporation +1 888 306 6843

Connie Mixon - CEO

Mark Clark - CFO

 

Numis Securities Limited +44 207 260 1000

Corporate Finance/Nominated Adviser

Alastair Stratton

Stuart Skinner

 

Corporate Broking

James Black

Ben Stoop

 

Pelham Bell Pottinger +44 207 861 3232

Mark Antelme

Nick Lambert

 

 

 

Notes for Editors

 

MyCelx Technologies Corporation is a clean water technology company that provides novel water treatment solutions to the oil and gas, power, marine and heavy manufacturing sectors

 

MyCelx invented and is the owner of the MyCelx polymer which is infused in the consumable media contained in equipment supplied by the Company

 

The technology produces treatment results that compare favourably to existing competition in effectiveness, cost and footprint. The MyCelx polymer and its use are protected by patents and other intellectual property rights

 

The defining difference of the MyCelx polymer as compared with alternative technologies currently available is that it is capable of permanently and reliably removing free, emulsified and dissolved hydrocarbons from water upon contact to levels between 0-10 parts per million (ppm) at any flow rate

 

MyCelx equipment has been installed successfully at the facilities of leading industry operators around the globe. The focus of the Company is now directed at the commercial application of MyCelx solutions in both upstream and downstream markets in the oil and gas industry

 

Over the last three years, the Company has sold its products primarily in North America, Asia, Australia, Middle East and Europe. Customers include such oil and gas companies as Chevron, BP, Anadarko Petroleum Corporation, SABIC, engineering, procurement and construction companies such as Mustang Engineering and global water treatment companies

 

Further information on MyCelx Technologies Corporation can be found at www.mycelx.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRFLLLFLKFXBBV
Date   Source Headline
14th Mar 20234:50 pmRNSClosure of Restricted Stock Line
13th Feb 20237:00 amRNSOperational Update
31st Jan 20237:00 amRNSTrading Update
8th Dec 20227:00 amRNSTrading Update
27th Sep 20227:00 amRNSHalf Year Results Statement
15th Sep 20227:00 amRNSTrading Update
6th Sep 20222:30 pmRNSHolding(s) in Company
30th Aug 20227:00 amRNSNew Project Awards and Operations Update
13th Jul 20223:32 pmRNSResult of Annual Meeting
13th Jun 20227:00 amRNS2021 Annual Report & Notice of 2022 Annual Meeting
17th May 20227:00 amRNSFinal Results for Year Ending 31 December 2021
3rd May 20227:00 amRNSDirector/PDMR Shareholding
3rd May 20227:00 amRNSChange of Main Office Address
23rd Mar 20229:17 amRNSTR1
21st Mar 20225:56 pmRNSBroker Option
9th Mar 20207:00 amRNSClosure of Restricted Stock Line
5th Mar 20207:00 amRNSTrading Update
13th Dec 201910:25 amRNSBlock listing Interim Review
4th Nov 20197:00 amRNSTrading Update
16th Sep 20197:00 amRNSHalf Year Results Statement
20th Aug 201912:42 pmRNSHolding(s) in Company
16th Aug 20193:02 pmRNSDirector Shareholding
29th Jul 20197:00 amRNSDirectorate Changes
26th Jul 20197:00 amRNSAppointment of Nominated Adviser & Broker
22nd Jul 20191:34 pmRNSHolding(s) in Company
10th Jul 201912:57 pmRNSResult of Annual Meeting
14th Jun 20197:00 amRNSTrading Update
11th Jun 20197:00 amRNSBlock listing Interim Review
6th Jun 20197:00 amRNSIssue of Equity
31st May 20191:57 pmRNSAnnual Financial Report
13th May 20197:00 amRNSFinal Results for the year ending 31 December 2018
28th Mar 20197:00 amRNSHolding(s) in Company
15th Mar 20197:00 amRNSHolding(s) in Company
15th Mar 20197:00 amRNSHolding(s) in Company
27th Sep 20172:44 pmRNSApplication for Block Admission
26th Sep 20175:31 pmRNSClosure of Restricted Stock Line
21st Sep 20177:00 amRNSConsolidation of Stock Lines
13th Sep 20177:00 amRNSHalf Year Results Statement
12th Jul 201712:30 pmRNSResult of Annual Meeting
7th Jul 20177:00 amRNSHalf Year Trading Update
9th Jun 201710:00 amRNSMailing of Annual Financial Report & GM Notice
7th Jun 201710:30 amRNSBlock listing Interim Review
30th May 20171:19 pmRNSDirector/PDMR Shareholding
26th May 20177:00 amRNSContract win with new SABIC affiliate customer
11th May 20177:00 amRNSFinal Results for the year ending 31 December 2016
8th May 20177:00 amRNSContract Award & Notification of Full Year Results
30th Jan 20177:00 amRNSTrading Update
7th Dec 20162:34 pmRNSBlock listing Interim Review
4th Oct 20167:00 amRNSAppointment of Nominated Adviser & Broker
14th Sep 20167:00 amRNSHalf Year Results Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.